MedCath Moves Toward Dissolution



A proxy statement to be filed with the U.S. Securities and Exchange Commission will request stockholder approval to authorize the MedCath board to dissolve the company, sell its remaining assets without further stockholder approval, and distribute available net proceeds to stockholders, the company says.


Name:
E-mail:
Website:  
Please enter your comment below:
Please enter the text below:

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2014 a division of BLR All rights reserved.